StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.64−0.00 (-0.28%)

Close on Nov 17, 2026Market cap $1.96MP/E –Yield –

DataMeds AI profit margin

Profit margin (net margin) is net income as a percentage of revenue.

DataMeds AI's profit margin for the twelve months ending Sep 30, 2026 was -564.8%. For fiscal 2025 it was -433.9%, against -37.8% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-433.9%−396.1
FY2024Dec 31, 2024-37.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026396.8%+1535.8
Q2 FY2026Jun 30, 2026-1031.7%−946.1
Q1 FY2026Mar 31, 2026-496.5%−197.9
Q4 FY2025Dec 31, 2025-1667.2%−1632.3
Q3 FY2025Sep 30, 2025-1139.0%−1106.1
Q2 FY2025Jun 30, 2025-85.6%+1203.8
Q1 FY2025Mar 31, 2025-298.5%–
Q4 FY2024Dec 31, 2024-34.9%–
Q3 FY2024Sep 30, 2024-32.9%–
Q2 FY2024Jun 30, 2024-1289.5%–

More DataMeds AI figures

See a number that looks wrong?